Since the early 1950's when Andard-Mount was first established, we have constantly striven - with some considerable success - to enhance our global position in the supply and manufacture of a 'state of the art' range of bulk active pharmaceutical materials, always backed and reinforced with well-founded experience which is fully available to our clientele.

In the areas of our specialisation we continue to maintain an increasingly important position and this is largely due to the integral strengths generated by our personnel and the linked cohesion of our Group. Our special strengths relate to Alkaloids, e.g. Capsaicin (since 1984), Buprenorphine (1993), Colchicine (1976) and Ergot Salts (1970); Steroids and precursors, e.g. Diosgenin, DPA, Progesterone, Estrone and Delta Compounds (since 1965); Biologicals, e.g.Gonadotrophins (1964), Heparins (1970). These compounds provide an indication of our product range and we suggest you kindly refer to the relative sections of our website for a fuller listing.

In your evaluation of the products currently mentioned in this web-site, you may wish also to consider the logical benefits of outsourcing. Since the inception of the industry, pharmaceutical concerns have needed to develop processes in order to manufacture active principles with the aims of: 
    • minimising development costs.
    • being first on the market.
    • lowest possible cost of product. 
and outsourcing can enable the viable resolution of these objectives through better utilisation of internal resources and lower demand for corporate financing. We are always ready to discuss, in absolute confidence, your potential requirements. 

Our Group holds an interesting and useful spectra of production processes and these would be available for your consideration. 
  
YOU ARE ALWAYS WELCOME AT OUR WEBSITE.


January 2012